Abstract
The study of proliferation and differentiation of acute myelogenous leukemia cells is greatly aided by the establishment of human myeloid leukemia cell lines [1–8], (Table 1 and Figure 1). The leukemic lines are blocked at different stages of maturation: The KG-la cells are very young myeloblasts; KG-1 are myeloblasts; HL-60 are promyelocytes; ML-1 and 3 are myelomonoblasts; U937 and THP-1 are monocytoid lines; K562 and HEL are early myeloid blasts and/or erythroblasts. Cells of each of the lines except THP-1 have prominent chromosomal abnormalities and these same changes were also present in the blast cells of the patients. The KG-1, ML-1 and 3, HL-60, THP-1 and U937 cells can be triggered to differentiate to macrophage-like cells. The HL-60 cells can differentiate to granulocytes. The K562 and HEL cells can differentiate to more mature red cell precursors after exposure to several agents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Lozzio CB, Lozzio BB: Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood 45:321–334, 1975.
Sundstron C, Nillsson K: Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 17:565–577, 1976.
Collins SJ, Gallo RC, Gallagher RE: Constinuous growth and differentiation of human myeloid leukemic cells in suspension culture. Nature 270:347–349, 1977.
Koeffler HP, Golde DW: Acute myelogenous leukemia: A human cell line responsive to colony-stimulating activity. Science 200:1153–1154, 1978.
Koeffler HP, Billing R, Sparkes RS, Golde DW: An undifferentiated strain derived from the human acute myelogenous leukemia cell line KG-1. Blood 56:265–273, 1980.
Takeda K, Minowada J, Bloch A: Kinetics of appearance of differentiation associated characteristics in ML-1, a line of human mycloblastic leukemia cells, after treatment with 12-O-tetradecanoylphorbol 13-acetate, dimethyl sulfoxide, 1-beta-D-arabinofuranosylcyto-sine. Cancer Res 42:5152–5158, 1981.
Martin P, Papayannopoulou T: HEL cells: A new human erythroleukemia cell line with spontaneous and induced globin expression. Science 216:1233–1235, 1982.
Tsuchiya S, Yamabe M, Yamaguchi Y, Kovayashi Y, Konno T, Tada K: Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 26:171–176, 1980.
Greenberger J, Parpas A, Gans P, Neumann H, Maloney W: Increased myeloid-associated enzymes in Epstein-Barr virus nuclear antigen-positive human cell lines exposed to butyric acid in vitro. Blood 51:1073–1085, 1978.
Monaco G, Vignetti E, Lancieri M et al.: Induction of monocyte-macrophage differentiation in a new diploid line of human hematopoietic cells (CM-5) by phorbol esters. Cancer Research 42:4182–4189, 1982.
Greenberg JS: Corticosteroid dependent differentiation of human bone marrow predipocytes. In Vitro 15:823–828, 1979.
Hocking WD, Golde DW: Long term human bone marrow cultures. Blood 56:118–124, 1980.
Gartner S, Kaplan H: Long term culture of human bone marrow cells. Proc Natl Acad Sci 77:4756–4759, 1980.
Greenberg H, Newburger P, Parker L, Novak T, Greenberger J: Human granulocytes generated in continuous bone marrow culture are physiologically normal. Blood 58:724–732, 1981.
Salahuddin S, Markham P, Ruscetti F, Gallo R: Long-term suspension cultures of human cord blood myeloid cells. Blood 58:931–938, 1981.
Mikko J, Ghamber C, Anderson L: Biosynthesis of the major human red cell sialoglyco-protein, glycophorin A1 in a continuous cell line. Nature 279:604–607, 1979.
Rutherford T, Clegg J, Weatherall D: K562 human leumaemic cells synthesize embryonic haemoglobin in response to haemin. Nature 280:164–165, 1979.
Cioe L, McNab A, Hubbell H et al.: Differential expression of the globin genes in human leukemia K562(s) cells induced to differentiate by hemin or butyric acid. Cancer Res 41:237–243, 1981.
Tonkonow B, Hoffman R, Burger D et al.: Differing responses of globin and glycophorin gene expression to hemin in the human leukemia cell line K562. Blood 59:738–746, 1982.
Erard F, Dean A, Schechter A: Inhibitors of cell division reversibly modify hemoglobin concentration in human erythroleukemia K562 cells. Blood 58:1236–1239, 1981.
Paran M, Sachs L, Barak Y, Resnitzky P: In vitro induction of granulocyte differentiation in hematopoietic cells from leukemic and non-leukemic patients. Proc Natl Acad Sci USA 67:1542–1549, 1970.
Robinson WA, Kurnick JE, Pike BL: Colony growth of human leukemic peripheral blood cells in vitro. Blood 38:500–504, 1971.
Golde DW, Beyers LA: Proliferation and maturation of human leukemia cells in liquid culture. In: Ito Y, Dutcher RM (eds Comparative Leukemia Research, 1973, Leukemogenesis, Tokyo, Univ Tokyo, 1975, p 243.
Elias L, Greenberg P: Divergent patterns of marrow cell suspension culture growth in the myeloid leukemias: Correlation of in vitro findings with clinical features. Blood 50:263–274, 1977.
Palu’ G, Powles R, Selby P, Summersgill B, Alexander P: Patterns of maturation in short-term culture of human acute myeloid leukemic cells. Br J Cancer 40:719–729, 1979.
Morley A, Higgs D: Abnormal differentiation of leukemic cells in vitro. Cancer 33:716–720, 1974.
Morley A, Higgs D: Lack of increased differentiation of leukemic cells in response to colony-stimulating factor. Cancer Res 34:2307–2310, 1974.
Moore MAS, Williams N, Metcalf D: In vitro colony formation by normal and leukemic human hematopoietic cells: Characterization of the colony-forming cells. J Natl Cancer Inst 50:603–623, 1973.
Marie JP, Izasuirre C, Civin C, Mirro J, McCulloch E: Granulopoietic differentiation in AML blasts in culture. Blood 58:670–674, 1981.
Fauerholdt L, Jacobsen N: Cultivation of leukemic human marrow cells in diffusion chambers transplanted into normal and inoculated mice. Blood 45:495–501, 1975.
Hoelzer Kurrle D, Schmucker E, Harriss H: Evidence of differentiation of human leukemic blood cells in diffusion chamber culture. Blood 49:729–744, 1977.
Steele, Sensenbrenner AA, Young LL: Growth and differentiation of normal and leukemic human bone marrow cells cultured in diffusion chambers. Exp Hematol 5:199–210, 1977.
Ichikawa Y: Differentiation of a cell line of myeloid leukemia. J Cell Physiol 74:223–234, 1969.
Sachs L: Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukemia. Nature 274:535–539, 1978.
Fibach E, Sachs L: Control of normal differentiation of myeloid leukemia cells. Induction of differentiation to mature granulocytes in mass culture. J Cell Physiol 86:221–230, 1975.
Honma Y, Kasukabe, Okabe J, Hozumi M: Prolongation of survival time of mice inoculated with myeloid leukemia cells by inducers of normal differentiation. Cancer Res 39:3167–3171, 1979.
Lotem J, Sachs L: In vivo inhibition of the development of myeloid leukemia by injection of macrophage-and granulocyte-inducing protein. Int J Cancer 28:375–386, 1981.
Gootwine E, Webb C, Sachs L: Participation of myeloic leukemic cells injected into embryos in hematopoietic differentiation in adult mice. Nature 299:63–65, 1982.
Collins SJ, Bodner A, Ting R, Gallo RC: Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL-60) by compounds which induce differentiation of murine Leukemia cells. Int J Cancer 25:213–218, 1980.
Bodner A, Ting R, Gallo R: Induction of differentiation of human promyelocytic leukemia cells (HL-60) by nucleosides and methotrexate. J. Natl Can. Inst. 67:1025–1030, 1980.
Lotem H, Sachs L: Potential pre-screening for therapeutic agents that induce differentiation in human myeloid leukemia cells. Int J Cancer 25:561–564, 1980.
Collins S, Ruscetti F, Gallagher R, Gallo R: Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci USA 75:2458–2462, 1978.
McPortland RP, Wang MC, Block A, Weinfeld H: Cytidine 5’triphosphate synthetase as a target for inhibition by the antitumor agent 3-deazauridine. Cancer Res 34:3107–3111, 1974.
Koeffler HP, Yen J, Carlson K: The study of human myeloid differentiation using bro-modeoxyuridine (BrdU). J Cell Physiol 116:111–117, 1983.
Honma Y, Kasukabe R, Hozumi M, Tsushima S, Nomura H: Induction of differentiation of cultured human and mouse myeloid leukemia cells by alkyllysophosphospholipids. Cancer Res 41:3211–3216, 1981.
Koeffler HP: The study of differentiation of fresh myelogenous leukemic cells by compounds that induce a human promyelocytic leukemic line (HL-60) to differentiate. Clinical Res 31:409A, 1983.
Forbes P, Dobbie D, Powles R, Alexander P: Maturation of human peripheral blood leukemic cells in short-term culture. Haematology and Blood Transfusion Vo. 26, pg 268–271, 1981. Ed. by Neth, Gallo, Graf, Mannweiler, Winkler Springer-Verlag, Berlin.
Breitman T, Collins S, Keene B: Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid. Blood 57:1000–1004, 1981.
Ip S, Cooper R: decreased membrane fluidity during differentiation of human promyelocytic leukemia cells in culture. Blood 56:227–232, 1980.
Bodner A, Tsai S, Ting R, Collins S, Gallo R: Isolation and characterization of thioguanine resistant human promyelocytic leukemia cells. Leukemia Res 4:151–154, 1980.
Koeffler HP, McAndrews P: Differentiation of myelogenous leukemia cells (HL-60) by purines and their analogues. (Personal communications).
Gusella J, Housman D: Induction of erythroid differentiation in vitro by purines and purine analogues. Cell 8263–269, 1976.
Griffin J, Munroe D, Major P, Kufe D: Induction of differentiation of human myeloid leukemia cells by inhibitors of DNA synthesis. Exp Hematol 9:774–781, 1982.
Luk G, Cuien C, Weissman R, Baylin S: Ornithine Decarboxylase: Essential in proliferation but not differentiation of human promyelocytec leukemic cells. Science 216:75–77, 1982.
Terada M, Epner E, Nudel V, Salmon S, Fibach E, Rifkind R, Marks P: Induction of murine erythroleukemia differentiation by actinomycin-D. Proc Natl Acad Sci USA 75:2795–2799, 1978.
Pantozia P, Soien P, Gallo R: Detection of a histone-2A related polypeptide in differentiated human myeloid cells (HL-60) and its distribution in human acute leukemia. Int J Cancer 27:585–592, 1981.
Friedman DL: Role of cyclic nucleotides in cell growth and differentiation. Physiol Rev 56û62–708, 1976.
Koeffler HP, Golde DW: Humoral modulation of human acute myelogenous leukemia cell growth in vitro. Cancer Res 40:1858–1862, 1982.
Chaplinski T, Niedel J: Cyclic nucleotide-induced maturation of human promyelocytic leukemia cells. J Clin Inv 70:953–964, 1982.
Olsson I, Breitman T, Gallo R: Priming of human myeloid leukemic cell lines HL-60 and U-937 with retinoic acid for differentiation effects of cyclic adenosine 3’:5’ monophosphate-inducing agents and a T-lymphocyte derived differentiation factor. Cancer Res 42:3928–3933, 1982.
Tarella C, Ferresa D, Galle R, Pagliardi L, Ruscetti F: Induction of differentiation of HL-60 cells by dimethyl sulfoxide: evidence of a stochastis model linked to the cell division cycle. Cancer Res 42:445–449, 1982.
Koeffler HP, Prokocimer M: Induction of granulocyte differentiation in a human leukemia cell line does not require cell division. Personnel comm.
Koeffler HP, Thomason A, Salser W: Role of DNA methylation in myeloid differentiation. Blood 58:74a, 1981.
Baluda M, Goeta I: Morphological conversion of cell cultures by avian myeloblastosis virus. Virology 15:1185–1199, 1961.
Westin E, Gallo R, Arya S, et al.: Differential expression of the AMV gene in human hematopoietic cells. Proc Natl Acad Sci 79:2194–2198, 1982.
Slamon D, Koeffler HP, Cline M: Change in expression of cellular oncogenes with differentiation of human myelogenous leukemia lines. J. Clin. Invest, (in press).
Roussel S, Saule C, Lagrou C, Rommeno H, Beug T, Graf D, Stehelin: Three new types of viral oncogenes of cellular origin specific for hematopoietic cell transformation. Nature 281:452, 1979.
Westin E, Wong-Staal F, Gelmann E, et al.: Expressing cellular homologues of retroviral onc genes in human hematopoietic cells. Proc Natl Sci 79:2490–2494, 1982.
Collins S, Groudine M: Amplication of endogenous myc-related DNA sequences in a human myeloid leukemia cell line. Nature 298:679–681, 1982.
Favera RD, Wong-Stall F, Gallo R: Onc gene amplification in promyelocytic leukemia cell line HL-60 and primary leukemic cells of the adult patient. Nature 299:61–63, 1982.
Lusis A, Koeffler HP: (personal communication).
Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680, 1970.
O’Farrell PH: High resolution two dimensional electrophoresis of protains. J Biol Chem 250:4007, 1975.
Rovera F, O’Breine TA, Diamond L: Induction of differentiation in human promyelocytic leukemia cells by tumor promoters. Science (Wash., D.C.) 204:268–272, 1979.
Koeffler HP, Bar-Eli M, Territo M: Phorbol ester effect on differentiation of human myeloid leukemia cell lines blocked at different stages of maturation. Cancer Res 41:919–924, 1979.
Olsson I, Olofsson T, Mauritzon N: Characterization of mononuclear blood cell-derived differentiation inducing factors for the human promyelocytic leukemia cell line HL-60. J Natl Cancer Inst 67:1225–1230, 1981.
Elias L, Wogenvich F, Wallace J, Longmire J: Altered pattern of differentiation and proliferation of HL-60 promyelocytic leukemia cells in the presence of leukocyte conditioned medium. Leukemia Research 4:301–307, 1980.
Chiao J, Frestag W, Stlenmetz J, Andreeff M: Changes of cellular markers during differentiation of HL-60 promyelocytes to macrophages as induced by T lymphocyte conditioned medium. Leukemia Research 5:477–489, 1981.
Yamamoto Y, Tomida M, Hozumi M: Production of mouse spleen cells of factors stimulating differentiation of mouse myeloid leukemic cells that differ from colony stimulating factor. Can Res 40:4804–4809, 1980.
Maeda M, Horittchi S, Numa S, Ichikawa Y: Characterization of a differentiation stimulating factor for mouse leukemia cells. Gann 68:435–447, 1977.
Lotem J, Lipton JH, Sachs L: Separation of different molecular forms of macrophage-and granulocyte-inducing proteins for normal and leukemic myeloid cells. Int J Cancer 25:763–771, 1980.
Burgess A, Metcalf D: Characterization of serum factor stimulating the differentiation of myelomonocytic leukemic cells. Int J Cancer 26:647–654, 1980.
Moore M: G-CSF: Its relationship to leukemia differentiation-inducing activity and other hematopoietic regulators. J Cell Phys Suppl 1:53–64, 1982.
Metcalf D: Induction of differentiation of murine myelomonocytic leukemia cells by the serum of patients with acute myeloid leukemia and other diseases. Int J Can 27:577–584, 1981.
Forkner LE: Leukemia and allied disorders. MacMillan, N.Y., 1938.
Findlay GM, McKenzie RD: The bone marrow in deficiency diseases. J Path 25:402–415, 1922.
Wolbach SB, Howe PR: Tissue changes following deprivatioin of fat soluble A vitamin. J Exp Med 42:753–777, 1925.
Hodges RE, Sauberlich HE, Canham JE, Wallace DL, Rucker RB, Mejia LA, Mohanram M: Hematopoietic studies in vitamin A deficiency. Am J Clin Nutr 31:876–885, 1978.
Douer D, Koeffler HP: Retinoic acid enhances colony-stimulating factor induced clonal growth of normal human myeloid progenitor cells in vitro. Exp Cell Res 138:193–198, 1982.
Douer D, Koefïler HP: Retinoic acid enhances growth of human early erythroid progenitor cells in vitro. J Clin Invest 69:1039–1041, 1982.
Lotan R: Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochem Biophys Acta 605:33–91, 1980.
Strickland S, Mahdavi V: The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 15:393–403, 1980.
Breitman TR, Selonic SE, Collins SJ: Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 77:2936–2940, 1980.
Douer D, Koefïler HP: Retinoic acid inhibition of the clonal growth of human myeloid leukemia cells. J Clin Invest 69:277–283, 1982.
Flynn R, Miller W, Weisdorf A, et al.: Treatment of acute promyelocytic leukemia with retinoic acid: Correlation with cell culture studies. Blood suppl 1:155a, 1982.
Gold E, Mertelsmann K, Itri L, Gee T, Clarkson B, Moore M: Phase I clinical trial of 13-cis-retinoie acid in myelodysplastic snydrome. Blood 62:107–111, 1983.
Takenaga K, Honma Y, Hozumi M: Cellular retinoid-binding proteins in cultured human and mouse myeloid leukemia cells. Cancer Letters 13:1–6, 1981.
Miyaura C, Abe E, Kuribayashi T, et al.: 1,25-dihydroxy vitamin D3 induces differentiation of human myeloid leukemia cells. Biochem Biophys Res Com 102:937–943, 1981.
McCarthy D, Miguel J, Freake H, Green P, Zola H, Catovsky D, Goldman J: 1,25-dihy-droxyvitamin D3 inhibits proliferation of mhuman promyelocytic leukaemia cells and induces monocyte-Macrophage differentiation in HL-60 and normal human bone marrow cells. Leuk Res 7:51–55, 1983.
Mangelsdorf D, Koeffler HP, Donaldson C, Haussier M, Pike J: Characterization of 1,25-dihydroxyvitamin D3-induced differentiation in a human promyelocyte leukemia cell line (HL-60). J Cell Biol 98:391–398, 1984.
Tomida M, Jamamoto Y, Hozumi M: Stimulation by interferon of induction of differentiation of human promyelocytic leukemia cells. Biochem and Biophys Res Comm 104:30–37, 1982.
Koeffler HP: Study of normal and abnormal hematopoiesis using human leukemic cells lines. UCLA Symposia on Molecular and Cellular biology, New Series, Vol. 9 Alan R. Liss, Inv., N.Y., N.Y., 1983, pp 179–195.
Verma D, Spitzer G, Zander A, et al.: Human leukocyte interferon preparation blocks granulopoietic differentiation. Blood 54:1423–1427, 1979.
Williams CK, Moldauskaya I, Wilcek J, Ohnuma T, Holland J: Inhibitory effects of human leukocyte and fibroblast interferons on normal and chronic myelogenous leukemic granulocyte progenitor cells. Oncology 38:356–360, 1981.
Lotem H, Sachs L: Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotion. Proc Natl Acad Sci USA 76:5158–5162, 1979.
Boecker WR, Oehl S, Hossfeld D, Schmidt C: Differentiation of Auer-rod positive leukemic cells in diffusion chamber culture. Lancet I, 267–269, 1978.
Niskanen E, Koeffler HP, Golde DW, Cline MS: Responsibeness of a human myelogenous leukemic cell line (KG-1) to humoral factors in vivo. Leukemia Res 4:203–204, 1982.
Lozzio B, Machado E, Mitchell J, Lozzio C, Wust C, Golde DW: Blood 61:1045–1053, 1983.
Krystosek A, Sachs L: Control of lysozyme induction in the differentiation of myeloid leukemic cells. Cell 9:675–684, 1976.
Honma Y, Okabe J, Kasukabe T, Hozumi M: Survival of mice inoculated with non-differentiating myeloid leukemia cells is prolonged by the injection of an inducer of cell differentiation with a sensitizer. Gann 71:543–547, 1980.
Symonds G, Sachs L: Modulation of cell competence for induction of differentiation in myeloid leukemic cells. J Cell Physiol 111:9–14, 1982.
Buick R, Minden M, McCulloch E: Self-renewal in culture of proliferative blast progenitor cells in acute myeloblastic leukemia. Blood 54:95–104, 1979.
Rovera G, Olashaw W, Pacifico M: Terminal differentiation of human leukemic cells in the absence of DNA synthesis. Nature 284:69–70, 1980.
Territo M, Koeffler HP: Induction by phorbol esters of macrophage differentiation in human leukemia cells lines does not require cell division. Brit J Hemat 47:479–483, 1981.
Metcalf D: Clonal extinction of myelomonocytic leukemic cells by serum from mice injected with endotoxin. Int J Cancer 25:225–233, 1980.
Koeffler P, Golde D: Cellular maturation in human preleukemia. Blood 52:355–361, 1978.
Huberman E, Callahan MP: Induction of terminal differentiation of human promyelocytic leukemia cells by tumor-promoting agents. Proc Natl Acad Sci Usa 76:293–297, 1979.
Huberman E, Callahan MF: Induction of terminal differentiation of human promyelocytic leukemia cells by tumor-promoting agents. Proc Natl Acad Sci USA 76:293–297, 1979.
Cooper R, Braunwald A, Kuo A: Phorbol ester induction of leukemic cell differentiation is a membrane-mediated process. Proc Natl Acad Sci USA 79:2865–2879, 1982.
Lehrer R, Cohen L, Koeffler HP: Specific binding of 3H-phorbol dibutryate to phorbol-diester responsive and resistant clones of a human myeloid leukemia (KG-1) line. Cancer Res (in press).
Niedel J, Kuhn L, Vandenbark G: Phorbol Diester receptor copurigies with protein kinase C. Proc Natl Acad Sci USA 80:36–40, 1983.
Pegoraro L, Abrahm J, Cooper R, Leuis A, Lange B, Meo P, Rovera G: Differentiation of human leukemias in response to 12-O-tetradecanoylphorbol 13-acetate in vitro, blood 55:859–862, 1980.
Koeffler HP, Bar-Eli M, Territo M: Phorbol diester-induced microphage differentiation of leukemic blasts from patient with human myelogenous leukemia. J Clin Inv 66:1101–1108, 1980.
Fyjiki H, Mori M, Nakayasu M, et al.: Indole alkaloids: Dihydroteleocidin B, teleocidin, and lyngbyatoxin A as members of a new class of tumor promoters. Proc Natl Acad Sci 78:3872–3876, 1981.
Huberman E, Braslowsky G, Callahan M, Fujiki H: Induction of differentiation of huan promyelocytic leukemia (HL-60) cells by teleocidin and phorbol-12-myristate 13-acetate. Carcinogenesis 3:111–114, 1982.
Koeffler HP, Groopman J, Territo M, Golde D: Teleocidins induce macrophagelike differentiation of acute myelogenous leukemia cells. Br J Hem (in press).
Chang L, McCulloch E: Dose-dependent effects of a tumor promoter on blast cell progenitors in human myeloblastic leukemia. Blood 57:361–367, 1981.
Koeffler HP: Human myelogenous leukemia: enhanced clonal proliferation in the presence of phorbol diesters. Blood 57:256–260, 1981.
Pegoraro L, Bagnara G, Bonsi L, et al.: Different responsiveness of colonyforming cells from normal subjects and chronic leukemia patients to 12-O-tetradecanoylphorbol 13-acetate (TPA). Cancer Res 41:5049–5051, 1981.
Ozawa K, Miura Y, Haskimoto Y, et al.: Effects of 12-O-tetradeconoyl 13-acetate (TPA) on the proliferation and differentiation of normal and leukemic myeloid progenitor cells. Cancer Res 43:2306–2310, 1983.
Abrahm JM, Simley R: Modification of normal human myelopoiesis by 12-O-tetradeca-noylyphorbol 13-lcetate (TPA). Blood 58:1119–1126, 1981.
Hirakawa T, Kakumaga T, Fujiki H, Sugimura T: A new tumor-promoting agent, dihydroteleocidin B, Markedly enhances chemically induced malignant cell transformation. Science 216:527–529, 1982.
Armuth VL: Leukaemogenic action of phorbol in intact and thymectomized mice of different strains. Br J Can 34:516, 1976.
Major P, Griffin J, Minden M, Kufe D: A blast subclone of the HL-60 human promyelocytic cell line. Leukemia Research 5:429–430, 1981.
Toksoz D, Bunce L, Stone P, Mitchell R, Brown G: Variant cell-lines from the human promyelocyte line HL-60. Leukemia Research 6:491–498, 1982.
Klein G, Zeuthen J, Eriksson I, Terasaki P, Bernoco M, Rosen A, Masucci G, Povery S, Ber R: Hybridization of a myeloid leukemia derived cell line (K562) with a burkett lymphoma line (P3HR-1). J Natl Can Inst 64:725–735, 1980.
Koeffler HP, Sparkes RS, Billing R, Klein G: Somatic cell hybrid analyses of hematopoietic differentiation. Blood 58:1159–1163, 1981.
Koeffler HP, Lusis AJ: Action of granulocyte-macrophage colony-stimulating factors: Studies using a human leukemia cell line. Proc Natl Acad Sci USA 22:5346–5350, 1980.
Koeffler HP: Unpublished observations.
Ruscetti F, Collins S, Woods A, Gallo R: Clonal analysis of the response of human myeloid leukemic cell lines to colony-stimulating activity. Blood 58:285–292, 1981.
Koeffler HP, Golde DW, Lippman MF: Glucocorticoid sensitivity and receptors in cells of human myelogenous leukemia lines. Cancer Res 40:563–566, 1980.
Crabtree GR, Munck A, Smith KA: Glucocorticoids inhibit expression of Fc Receptors on the human granulocyte cell line HL-60. nature 269:338–340, 1970.
Brendt SJ Bank KC, Glass DB, Kinkade JM: Glucocorticoid-stimulated increase in che-motactic peptide receptors on differentiating human myeloid leukemia (HL-60) cells. Cancer Res 41:4947–4951, 1971.
Skubitz K, Zhen Y, August T: Dexamethasone synergistically induced chemotactic peptide receptor expression in HL-60 cells. Blood 59:586–593, 1982.
Rogol A, Meyer W, Johnson M: Insulin binding to the HL-60 human promyelocytic cell line. Mol & Cell End 25:105–112, 1982.
Danel L, Cordier G, Revillard J, Saez S: Presence of estrogen binding sites and growth-stimulating effect of estradiol in the human myelogenous cell line HL-60. Cancer Res 42:4701–4705, 1982.
Oscier D, Hillgard C, Arnett T, Maclntyre I, Goldman J: Immunoreactive calcitonin production by a human promyelocytic leukemia cell line HL-60. Blood 61:61–65, 1983.
Earle WB, Bryant JC, Schilling EL: Certain factors limiting the size of the tissue cultures and the development of massive cultures. An Ny Acad Sci 58:1000–1005, 1954.
Puck T, Marcus P: A rapid method for viable cell titration and clone production with Hela cells in tissue culture: the use of X-irradiated cells to supply conditioning factors. Proc Natl Acad Sci Usa 41:432–437, 1955.
Todaro G, Fryling C, DeLarco J: Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc natl Acad Sci USA 77:5258–5264, 1980.
Roberts A, Anzano M, Lamb L, Smith J, Sporn M: New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc Natl Acad Sci 78:5339–5343, 1981.
Moore MAS: In vitro studies in the myeloid leukemias. Advances in Acute Leukemia (Cleton FJ, Crowther D, Malpas JB, eds). Amster, North-Holland, p 161, 1975.
Burgess A, Metcalf D: The nature and action of granulocyte-macrophage colony stimulating factors. Blood 56:947–958, 1980.
Price G, Senn J, McCulloch E, Till J: Heterogeneity of molecules with low molecular weight isolated from media conditioned by human leukocytes and capable of stimulating colony formation by human granulopoietic progenitor cells. J Cell Physiol 84:383–396, 1975.
Golde DW, Rothman B, Cline MJ: Production of colony-stimulating factor by malignant leukocytes. Blood 43:749–756, 1974.
Goldman K, Th’ng D, Catovsky D: Production of colony-stimulating factor by leukemic leukocytes. Blood 47:381–388, 1976.
Metcalf D, Moore M, Warner M: Colony formation in vitro by myelomonocytic leukemic cells. J Natl Cane Inst 43:983–997, 1969.
Metcalf D, Moore M: Factors modifying item cell proliferation of myelomonocytic leukemic cells in vitro and in vivo. J Natl Canc Inst 44:801–808, 1970.
Brennan J, Abbaud C, DiPersio J, Barlow G, Lichtman M: Autostimulation of growth by human myelogenous leukemia cells (HL-60). Blood 58:803–812, 1981.
Koeffler HP, Yen J, Lowe L: An in vitro model for acute myelogenous leukemia chemotherapy. Cancer 48:1958–1963, 1981.
Akman S, Ross D, Rosen H et al.: Growth inhibition by thymidine of leukemic HL-60 and normal human myeloid progenitor cells. Cancer Res 41:2141–2146, 1981.
Grant S, Rauscher F, Margolin J, Cadman E: Dose-and schedule dependent activation and drug synergism between thymidine and 5-Aza-2’-Deoxycytidine in a human promyelocytic leukemia cell line. Cancer Res. 42:519–524, 1982.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Martinus Nijhoff Publishers, Boston
About this chapter
Cite this chapter
Koeffler, H.P. (1985). Study of Differentiation and Proliferation of Leukemic Cells Using Myeloid Leukemia Cell Lines. In: Bloomfield, C.D. (eds) Chronic and Acute Leukemias in Adults. Cancer Treatment and Research, vol 26. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2581-9_2
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2581-9_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9619-5
Online ISBN: 978-1-4613-2581-9
eBook Packages: Springer Book Archive